Direct oral anticoagulants in antiphospholipid syndrome

被引：2
|
作者：
de Carvalho, Jozelio Freire [1 ]
Oliveira de Andrade, Daniele Castro [2 ]
Levy, Roger A. [3 ]
机构：
[1] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil
[2] Univ Sao Paulo, Fac Med, Div Reumatol, Sao Paulo, SP, Brazil
[3] Univ Estado Rio de Janeiro, Div Reumatol, Rio De Janeiro, RJ, Brazil
来源：
REVISTA BRASILEIRA DE REUMATOLOGIA | 2016年 / 56卷 / 06期
关键词：
THROMBOEMBOLISM; RIVAROXABAN;
D O I：
10.1016/j.rbre.2016.09.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [41] Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
    Pastori, Daniele
    Menichelli, Danilo
    Cammisotto, Vittoria
    Pignatelli, Pasquale
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [42] Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort
    Franke, Benjamin
    Luxembourg, Beate
    Heidinger, Kathrin
    Kemkes-Matthes, Bettina
    Sachs, Ulrich J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2022, 33 (03) : 184 - 187
  • [43] Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis
    Sanchez-Redondo, Jorge
    Espinosa, Gerard
    Varillas Delgado, David
    Cervera, Ricard
    CLINICAL THERAPEUTICS, 2019, 41 (09) : 1839 - 1862
  • [44] Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
    Briana Williams
    Joseph J. Saseen
    Toby Trujillo
    Surabhi Palkimas
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 67 - 73
  • [45] Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
    Williams, Briana
    Saseen, Joseph J.
    Trujillo, Toby
    Palkimas, Surabhi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (01) : 67 - 73
  • [46] Direct Oral Anticoagulants in Acute Coronary Syndrome
    Ahrens, Ingo
    Bode, Christoph
    SEMINARS IN HEMATOLOGY, 2014, 51 (02) : 147 - 151
  • [47] Response to letter to the Editor: Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension
    Bunclark, Katherine
    Ansaripour, Ali
    Sheares, Karen
    Toshner, Mark
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (03) : 756 - 757
  • [48] Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome
    Sciascia, Savino
    Lopez-Pedrera, Chary
    Cecchi, Irene
    Pecoraro, Clara
    Roccatello, Dario
    Cuadrado, Maria Jose
    RHEUMATOLOGY, 2016, 55 (10) : 1726 - 1735
  • [49] Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials
    Lee, Young H.
    Song, Gwan G.
    LUPUS, 2022, 31 (11) : 1335 - 1343
  • [50] Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature
    Virginie Dufrost
    Jessie Risse
    Stéphane Zuily
    Denis Wahl
    Current Rheumatology Reports, 2016, 18
12345